Address
Other Office
1901 Olathe Boulevard
Kansas City, KS 66103
United States
Website
Industry
VCID: 2510
Profile
Corporate information
Official name
MPM Asset Management Limited Liability Company
Registration country
Official name
MPM Asset Management Limited Liability Company
Registration country
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. |
United States | N/A Active |
|
|
|
EKR Therapeutics Inc |
United States | N/A |
|
|
|
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity |
United States | N/A |
|
|
|
Poniard Pharmaceuticals Inc Develops and commercializes oncology products. |
United States | N/A |
|
|
|
Solasia Pharma KK |
Japan | N/A |
|
|
|
Xanodyne Pharmaceuticals Inc Specialty pharmaceuticals for pain and women's health |
United States | N/A |
|
|
|
Cardiac Dimensions Inc Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. |
United States | N/A |
|
|
|
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to |
United States | N/A |
|
|
|
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
United States | N/A Active |
|
|
|
PrimeraDx Inc Provider of Scalable Target Amplification Routine technology. |
United States | N/A |
|
|
|
Somaxon Pharmaceuticals Inc |
United States | N/A |
|
|
|
Zalicus Inc Combination drug development |
United States | N/A |
|
|
|
Portola Pharmaceuticals Inc |
United States | N/A Active |
|
|
|
Celladon Corp |
United States | N/A |
|
|
|
Epigenomics |
Germany | N/A |
|
|
|
NeoVista Inc |
United States | N/A |
|
|
|
Proteon Therapeutics Inc |
United States | N/A |
|
|
|
Syndax Pharmaceuticals Inc A clinical development company focused on novel oral therapies for cancer. |
United States | N/A Active |
|
|
|
EndoGastric Solutions Inc |
United States | N/A Initial investment. Round participant. Active |
|
|
|
Allozyne Inc |
United States | N/A Active |